[English] 日本語
Yorodumi
- PDB-1oqd: Crystal structure of sTALL-1 and BCMA -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1oqd
TitleCrystal structure of sTALL-1 and BCMA
Components
  • Tumor necrosis factor ligand superfamily member 13B, soluble form
  • Tumor necrosis factor receptor superfamily member 17
KeywordsIMMUNE RESPONSE / ligand receptor complex
Function / homology
Function and homology information


B cell costimulation / positive regulation of germinal center formation / lymphocyte homeostasis / TNFs bind their physiological receptors / TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway / transitional one stage B cell differentiation / germinal center formation / tumor necrosis factor receptor binding / skin development / B cell proliferation ...B cell costimulation / positive regulation of germinal center formation / lymphocyte homeostasis / TNFs bind their physiological receptors / TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway / transitional one stage B cell differentiation / germinal center formation / tumor necrosis factor receptor binding / skin development / B cell proliferation / B cell homeostasis / endomembrane system / positive regulation of T cell proliferation / T cell proliferation / positive regulation of B cell proliferation / tumor necrosis factor-mediated signaling pathway / T cell costimulation / cytokine activity / TNFR2 non-canonical NF-kB pathway / signaling receptor activity / adaptive immune response / receptor ligand activity / intracellular membrane-bounded organelle / signaling receptor binding / focal adhesion / perinuclear region of cytoplasm / signal transduction / extracellular space / extracellular region / membrane / plasma membrane / cytoplasm
Similarity search - Function
BCMA, TALL-1 binding / Tumour necrosis factor receptor 17 / BCMA, TALL-1 binding / Tumor necrosis factor receptor 13C/17 / : / TNF(Tumour Necrosis Factor) family / Tumour necrosis factor domain / Tumor necrosis factor (TNF) homology domain (THD) profile. / Jelly Rolls - #40 / Tumour necrosis factor-like domain superfamily ...BCMA, TALL-1 binding / Tumour necrosis factor receptor 17 / BCMA, TALL-1 binding / Tumor necrosis factor receptor 13C/17 / : / TNF(Tumour Necrosis Factor) family / Tumour necrosis factor domain / Tumor necrosis factor (TNF) homology domain (THD) profile. / Jelly Rolls - #40 / Tumour necrosis factor-like domain superfamily / Jelly Rolls / Sandwich / Mainly Beta
Similarity search - Domain/homology
Tumor necrosis factor receptor superfamily member 17 / Tumor necrosis factor ligand superfamily member 13B
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / FOURIER SYNTHESIS / Resolution: 2.6 Å
AuthorsZhang, G.
CitationJournal: Nature / Year: 2003
Title: Ligand-receptor binding revealed by the TNF family member TALL-1.
Authors: Liu, Y. / Hong, X. / Kappler, J. / Jiang, L. / Zhang, R. / Xu, L. / Pan, C.H. / Martin, W.E. / Murphy, R.C. / Shu, H.B. / Dai, S. / Zhang, G.
History
DepositionMar 7, 2003Deposition site: RCSB / Processing site: RCSB
Revision 1.0May 13, 2003Provider: repository / Type: Initial release
Revision 1.1Apr 29, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Tumor necrosis factor ligand superfamily member 13B, soluble form
B: Tumor necrosis factor ligand superfamily member 13B, soluble form
C: Tumor necrosis factor ligand superfamily member 13B, soluble form
D: Tumor necrosis factor ligand superfamily member 13B, soluble form
E: Tumor necrosis factor ligand superfamily member 13B, soluble form
F: Tumor necrosis factor ligand superfamily member 13B, soluble form
G: Tumor necrosis factor ligand superfamily member 13B, soluble form
H: Tumor necrosis factor ligand superfamily member 13B, soluble form
I: Tumor necrosis factor ligand superfamily member 13B, soluble form
J: Tumor necrosis factor ligand superfamily member 13B, soluble form
K: Tumor necrosis factor receptor superfamily member 17
L: Tumor necrosis factor receptor superfamily member 17
M: Tumor necrosis factor receptor superfamily member 17
N: Tumor necrosis factor receptor superfamily member 17
O: Tumor necrosis factor receptor superfamily member 17
P: Tumor necrosis factor receptor superfamily member 17
Q: Tumor necrosis factor receptor superfamily member 17
R: Tumor necrosis factor receptor superfamily member 17


Theoretical massNumber of molelcules
Total (without water)197,41418
Polymers197,41418
Non-polymers00
Water00
1
A: Tumor necrosis factor ligand superfamily member 13B, soluble form
B: Tumor necrosis factor ligand superfamily member 13B, soluble form
C: Tumor necrosis factor ligand superfamily member 13B, soluble form
D: Tumor necrosis factor ligand superfamily member 13B, soluble form
E: Tumor necrosis factor ligand superfamily member 13B, soluble form
F: Tumor necrosis factor ligand superfamily member 13B, soluble form
G: Tumor necrosis factor ligand superfamily member 13B, soluble form
H: Tumor necrosis factor ligand superfamily member 13B, soluble form
I: Tumor necrosis factor ligand superfamily member 13B, soluble form
J: Tumor necrosis factor ligand superfamily member 13B, soluble form
K: Tumor necrosis factor receptor superfamily member 17
L: Tumor necrosis factor receptor superfamily member 17
M: Tumor necrosis factor receptor superfamily member 17
N: Tumor necrosis factor receptor superfamily member 17
O: Tumor necrosis factor receptor superfamily member 17
P: Tumor necrosis factor receptor superfamily member 17
Q: Tumor necrosis factor receptor superfamily member 17
R: Tumor necrosis factor receptor superfamily member 17
x 6


Theoretical massNumber of molelcules
Total (without water)1,184,481108
Polymers1,184,481108
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation12_564x,x-y+1,-z-1/21
crystal symmetry operation11_554-x+y,y,-z-1/21
crystal symmetry operation10_664-y+1,-x+1,-z-1/21
crystal symmetry operation3_565-x+y,-x+1,z1
crystal symmetry operation2_665-y+1,x-y+1,z1
Unit cell
Length a, b, c (Å)232.854, 232.854, 212.477
Angle α, β, γ (deg.)90.00, 90.00, 120.00
Int Tables number182
Space group name H-MP6322

-
Components

#1: Protein
Tumor necrosis factor ligand superfamily member 13B, soluble form / TNF-and APOL- related leukocyte expressed ligand 1 / TALL-1 / B lymphocyte stimulator / BLyS / B ...TNF-and APOL- related leukocyte expressed ligand 1 / TALL-1 / B lymphocyte stimulator / BLyS / B cell-activating factor / BAFF / Dendritic cell- derived TNF-like molecule


Mass: 16244.602 Da / Num. of mol.: 10 / Fragment: extracellular domain
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli) / References: UniProt: Q9Y275
#2: Protein/peptide
Tumor necrosis factor receptor superfamily member 17 / B-cell maturation protein


Mass: 4370.944 Da / Num. of mol.: 8 / Fragment: extracellular domain
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli) / References: UniProt: Q02223

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 4.21 Å3/Da / Density % sol: 70.78 %
Crystal growTemperature: 277 K / Method: vapor diffusion, hanging drop / pH: 9
Details: dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Crystal grow
*PLUS
Method: vapor diffusion / Details: Liu, Y., (2002) Cell, 108, 383.
Components of the solutions
*PLUS
IDConc.Common nameCrystal-IDSol-IDDetailsChemical formula
115 mg/mlprotein1drop
25 mMbeta-mercaptoethanol1reservoir
350 mMBicine1reservoirpH9.0
4150 mM1reservoirNaCl
535-38 %dioxane1reservoir

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 19-ID / Wavelength: 1 Å
DetectorType: ADSC QUANTUM 4 / Detector: CCD / Date: Mar 1, 2002 / Details: mirrors
RadiationMonochromator: GRAPHITE / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 2.6→50 Å / Num. obs: 1056776 / % possible obs: 87.8 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 / Redundancy: 3 % / Biso Wilson estimate: 18.4 Å2 / Rmerge(I) obs: 0.136 / Rsym value: 0.118 / Net I/σ(I): 10
Reflection shellResolution: 2.6→2.69 Å / Redundancy: 3 % / Rmerge(I) obs: 0.6 / Mean I/σ(I) obs: 58 / Num. unique all: 18286 / % possible all: 46.2
Reflection
*PLUS
Num. obs: 97672 / % possible obs: 94 % / Num. measured all: 1056950 / Rmerge(I) obs: 0.129
Reflection shell
*PLUS
Rmerge(I) obs: 0.55

-
Processing

Software
NameVersionClassification
CNS1refinement
DENZOdata reduction
SCALEPACKdata scaling
CNSphasing
RefinementMethod to determine structure: FOURIER SYNTHESIS / Resolution: 2.6→19.87 Å / Rfactor Rfree error: 0.007 / Isotropic thermal model: RESTRAINED / Cross valid method: THROUGHOUT / σ(F): 0 / Stereochemistry target values: Engh & Huber
RfactorNum. reflection% reflectionSelection details
Rfree0.26 1554 2 %RANDOM
Rwork0.24 ---
obs0.24 78303 75.5 %-
all-97675 --
Solvent computationSolvent model: FLAT MODEL / Bsol: 31.1475 Å2 / ksol: 0.321443 e/Å3
Displacement parametersBiso mean: 50.2 Å2
Baniso -1Baniso -2Baniso -3
1-2.97 Å28.35 Å20 Å2
2--2.97 Å20 Å2
3----5.93 Å2
Refine analyze
FreeObs
Luzzati coordinate error0.41 Å0.38 Å
Luzzati d res low-5 Å
Luzzati sigma a0.62 Å0.59 Å
Refinement stepCycle: LAST / Resolution: 2.6→19.87 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms13704 0 0 0 13704
Refine LS restraints
Refine-IDTypeDev ideal
X-RAY DIFFRACTIONc_bond_d0.009
X-RAY DIFFRACTIONc_bond_d_na
X-RAY DIFFRACTIONc_bond_d_prot
X-RAY DIFFRACTIONc_angle_d
X-RAY DIFFRACTIONc_angle_d_na
X-RAY DIFFRACTIONc_angle_d_prot
X-RAY DIFFRACTIONc_angle_deg1.5
X-RAY DIFFRACTIONc_angle_deg_na
X-RAY DIFFRACTIONc_angle_deg_prot
X-RAY DIFFRACTIONc_dihedral_angle_d26.9
X-RAY DIFFRACTIONc_dihedral_angle_d_na
X-RAY DIFFRACTIONc_dihedral_angle_d_prot
X-RAY DIFFRACTIONc_improper_angle_d0.91
X-RAY DIFFRACTIONc_improper_angle_d_na
X-RAY DIFFRACTIONc_improper_angle_d_prot
X-RAY DIFFRACTIONc_mcbond_it
X-RAY DIFFRACTIONc_mcangle_it
X-RAY DIFFRACTIONc_scbond_it
X-RAY DIFFRACTIONc_scangle_it
Refine LS restraints NCSNCS model details: CONSTR
LS refinement shellResolution: 2.6→2.76 Å / Rfactor Rfree error: 0.029 / Total num. of bins used: 6
RfactorNum. reflection% reflection
Rfree0.356 156 2.2 %
Rwork0.356 7062 -
obs--42.3 %
Xplor file
Refine-IDSerial noParam fileTopol file
X-RAY DIFFRACTION1PROTEIN_REP.PARAMPROTEIN.TOP
X-RAY DIFFRACTION2CARBOHYDRATE.PARAM
X-RAY DIFFRACTION3WATER.PARAM
Refinement
*PLUS
Highest resolution: 2.6 Å / % reflection Rfree: 5 % / Rfactor Rfree: 0.235 / Rfactor Rwork: 0.209
Solvent computation
*PLUS
Displacement parameters
*PLUS
Refine LS restraints
*PLUS
Refine-IDTypeDev ideal
X-RAY DIFFRACTIONc_dihedral_angle_d
X-RAY DIFFRACTIONc_dihedral_angle_deg26.9
X-RAY DIFFRACTIONc_improper_angle_d
X-RAY DIFFRACTIONc_improper_angle_deg0.91
LS refinement shell
*PLUS
Rfactor Rfree: 0.36 / Rfactor Rwork: 0.338

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more